Delafloxacin

Quofenix 300 mg, poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 16 Dec 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

QuofenixEuropean UnionAuthorised

QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONSpain · 310 mg · polvo para concentrado para solución para perfusión · A. Menarini Industrie Farmaceutiche Riunite S.R.L.Same brand
QUOFENIX 450 mg COMPRIMIDOSSpain · 649,35 mg · comprimido · A. Menarini Industrie Farmaceutiche Riunite S.R.L.Same brand
QuofenixEuropean Union · A. Menarini Industrie Farmaceutiche Riunite s.r.l.Same brand
QuofenixCroatiaSame brand
QuofenixItaly · Compressa · A. Menarini Industrie Farmaceutiche Riunite S.R.L.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Delafloxacin

Quofenix 300 mg, poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 16 Dec 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

QuofenixEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

DelabaxiBrazil · Eurofarma Laboratorios S.A.

delafloxacino megluminaBrazil · Eurofarma Laboratorios S.A.

BaxdelaCanada · 300 MG / VIAL · Powder For Solution · Xediton Pharmaceuticals INC

BaxdelaCanada · 450 MG · Tablet · Xediton Pharmaceuticals INC

BaxdelaSaudi Arabia · Patheon Italia S.P.A.

BaxdelaSaudi Arabia · AustarPharma LLC

BaxdelaUnited States · 300MG BASE/VIAL · powder · Melinta

BaxdelaUnited States · 450MG BASE · tablet · Melinta

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Delafloxacin
Dosage form: Poeder voor concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 16 Dec 2019
Registration: EU/1/19/1393
Marketing authorisation holder: A. Menarini Industrie Farmaceutiche Riunite S.r.l.
ATC code: J01MA23
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/004860
EU number: EU/1/19/1393